Skip to main content
SpringerLink
Log in

Androstenedione and androst-5-ene-3β,17β-diol stimulate DMBA-induced rat mammary tumors — role of aromatase

  • Report
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Summary

The effect of the adrenal steroids androst-5-ene-3β,17β-diol (Δ5-diol) and androstenedione (Δ4-dione) was studied on the growth of mammary carcinoma induced in the rat by dimethylbenz[a]anthracene (DMBA). The plasma levels of the two steroids were maintained at values within the range of those found in the circulation of post-menopausal women by constant release from osmotic pumps in ovariectomized animals. Δ5-diol and Δ4-dione, at the daily release rate of 500µg, led to plasma levels of 1.26±0.19 and 1.72 ± 0.75 ng/ml, respectively. At these physiologically relevant plasma concentrations, both Δ5-diol and Δ4-dione caused a marked stimulation of tumor growth while having minimal or no effect on uterine weight or on plasma prolactin and LH levels.

Concomitant treatment with the aromatase inhibitor aminoglutethimide completely blocked the stimulatory effect of Δ4-dione released from silastic implants on tumor growth, while simultaneous administration of the antiandrogen flutamide had no significant effect. On the other hand, when aminoglutethimide was administered with Δ5-diol, the stimulatory effect of the adrenal steroid on tumor growth was not affected. Such data indicate that, under the present experimental conditions, transformation of Δ4-dione into androgens plays a minor role, the predominant effect of the adrenal steroid being stimulation of tumor growth through conversion into estrogens, while Δ5-diol exerts a direct estrogenic effect independent from aromatase activity. The minimal or absent effect of the same treatment on uterine weight and on plasma prolactin and LH levels indicates the tissue specificity of the effects observed, the mammary tissue being most sensitive to the action of adrenal steroids.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. McGuire WL, Carbone PP, Sears ME, Escher GC: Estrogen receptors in human breast cancer: an overview. In: McGuire WL, Carbone PP, Vollmer EP (eds) Estrogen Receptors in Human Breast Cancer. Raven Press, New York, 1975, pp 1–7

    Google Scholar 

  2. Pichon MF, Pallud C, Brunet M, Milgrom E: Relationship of presence of progesterone receptors to prognosis in early breast cancer. Cancer Res 40: 3357–3360, 1980

    PubMed  Google Scholar 

  3. Huggins C, Briziarelli G, Sutton Jr H: Rapid induction of mammary carcinoma in the rat and the influence of hormones on the tumors. J Exp Med 109: 25–41, 1959

    PubMed  Google Scholar 

  4. Asselin J, Kelly PA, Caron MG, Labrie F: Control of hormone receptor levels and growth of 7,12-dimethylbenz (a)anthracene-induced mammary tumors by estrogens, progesterone, and prolactin. Endocrinology 101: 666–671, 1977

    PubMed  Google Scholar 

  5. Welsch CW: Host factors affecting the growth of carcinogen-induced rat mammary carcinomas: a review and tribute to Charles Brenton Huggins. Cancer Res 45: 3415–3443, 1985

    PubMed  Google Scholar 

  6. Leung BS, Sasaki GH, Leung JS: Estrogen-prolactin dependency in 7,12-dimethylbenz(a)anthracene-induced tumors. Cancer Res 35: 621–627, 1975

    PubMed  Google Scholar 

  7. Asselin J, Labrie F: Effects of estradiol and prolactin on steroid receptor levels in 7,12-dimethylbenz(a)anthraceneinduced mammary tumors and uterus in the rat. J Steroid Biochem 9: 1079–1082, 1977

    Google Scholar 

  8. Spinola PG, Marchetti B, Labrie F: Adrenal steroids stimulate growth and progesterone receptor levels in rat uterus and DMBA-induced mammary tumors. Breast Cancer Res Treat 8: 241–248, 1986

    PubMed  Google Scholar 

  9. Miller WR, Forrest APM, Hamilton T: Steroid metabolism by human breast and rat mammary carcinomata. Steroids 23: 379–395, 1976

    Google Scholar 

  10. Maroulis GB, Abraham GE: Ovarian and adrenal contribution to peripheral steroid levels in post-menopausal women. Obstet Gynecol 48: 150–154, 1976

    PubMed  Google Scholar 

  11. Rosenfield RL, Otto P: Androstenediol levels in human peripheral plasma. J Clin Endocrinol Metab 35: 818–822, 1972

    PubMed  Google Scholar 

  12. Crilly RG, Marshall DH, Nordin BEC: Adrenal androgens in post-menopausal osteoporosis. In: Genazzaniet al. (eds) Adrenal Androgens. Raven Press, New York, 1980, pp 241–258

    Google Scholar 

  13. Bélanger A, Picard V, Caron S: Simultaneous radioimmunoassay of progestins, androgens, and estrogens in the rat testis. J Steroid Biochem 13: 185–191, 1985

    Google Scholar 

  14. Rodbard D, Lewald JE: Computer analysis of radioligand assay and radioimmunoassay data. In: Diczfalusy E (eds): 2nd Karolinska Symposium in Research Methods in Reproductive Endocrinology. Copenhagen, Bogtrykleriet Forum, 1970, p 79–103

    Google Scholar 

  15. Kramer CY: Extension of multiple range tests to group means with unequal numbers of replication. Biometrics 12: 307–310, 1956

    Google Scholar 

  16. Lippman ME: Antiestrogen therapy of breast cancer. Semin Oncol 10 (suppl. 4): 11–19, 1983

    PubMed  Google Scholar 

  17. Sledge GW Jr, McGuire WL: Steroid hormone receptors in human breast cancer. Adv Cancer Res 38: 61–75, 1984

    Google Scholar 

  18. Wittliff JL: Steroid-hormone receptors in breast cancer. Cancer 53: 630–643, 1984

    PubMed  Google Scholar 

  19. Adams JB: Control of secretion and the function of C19-Δ5-steroids of the human adrenal gland. Mol Cell Endocrinol 41: 1–17, 1985

    PubMed  Google Scholar 

  20. Rochefort H, Garcia M: The estrogenic and antiestrogenic activities of androgens in female target tissues. Pharmacol Ther 23: 193–216, 1984

    Google Scholar 

  21. Seymour-Munn K, Adams JB: Estrogenic effects of 5-an-drostene-3β, 17β-diol at physiological concentrations and its possible implication in the etiology of breast cancer. Endocrinology 112: 486–491, 1983

    PubMed  Google Scholar 

  22. Adams JB, Garcia M, Rochefort H: Estrogenic effects of physiological concentrations of 5-androstene-3β,17β-diol and its metabolism in MCF-7 human breast cancer cells. Cancer Res 41: 4720–4726, 1981

    PubMed  Google Scholar 

  23. Kreitmann B, Bayard F: Androgen interaction with the oestrogen receptor in human tissues. J Steroid Biochem 11: 1589–1595, 1979

    PubMed  Google Scholar 

  24. Poulin R, Labrie F: Stimulation of cell proliferation and estrogenic response by adrenal C19-Δ5-steroids in the ZR-75-1 human breast cancer cell line. Cancer Res 46: 4933–4937, 1986

    PubMed  Google Scholar 

  25. Siiteri PK, McDonald DC: The role of extraglandular estrogens in human endocrinology. In: Geiger SR, Astwood EB, Greep RO (eds) Handbook of Physiology, Section 7. The American Physiology Society, New York, 1973, pp 615–619

    Google Scholar 

  26. Carlström K: Influence of intratumoral estradiol biosynthesis on estrogen receptors. In: Leclercq G, Toma S, Paridaens R, Heuson JC (eds) Recent Results in Cancer Research, Vol. 91. Springer-Verlag, Berlin 1984, pp 145–149

    Google Scholar 

  27. Teller MN, Stock CC, Bowie M: Effects of 17α-thioestradiol, two estradiol analogs, and two androgens on 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors. Cancer Res 26: 2329–2331, 1966

    PubMed  Google Scholar 

  28. Huggins C, Mainzer K: Hormonal influences on mammary tumors of the rat. II. Retardation of growth of a transplanted fibroadenoma in intact female rats by steroids in the androstane series. J Exp Med 105: 485–499, 1957

    PubMed  Google Scholar 

  29. King RJB, Panattoni M, Gordon J, Baker R: The metabolism of steroids by tissue from normal and neoplastic rat breast. J Endocrinol 33: 127–132, 1965

    PubMed  Google Scholar 

  30. Neri R, Florance K, Koziol P, Van Cleave S: A biological profile of a non steroidal antiandrogen, SCH 13521, 4′-nitro-3′-trifluoromethylisobutyranilide. Endocrinology 91: 427–437, 1972

    PubMed  Google Scholar 

  31. Poyet P, Labrie F: Comparison of the antiandrogenic/androgenic activities of flutamide, cyproterone acetate, and megestrol acetate. Mol Cell Endocrinol 32: 283–288, 1985

    Google Scholar 

  32. Simard J, Luthy I, Guay J, Bélanger A, Labrie F: Characteristics of interaction of the antiandrogen flutamide with the androgen receptor in various target tissues. Mol Cell Endocrinol 44: 261–270, 1986

    PubMed  Google Scholar 

  33. Labrie C, Cusan L, Plante M, Lapointe S, Labrie F: Analysis of the androgenic activity of synthetic ‘progestins’ currently used for the treatment of prostate cancer. J Steroid Biochem 28: 379–384, 1987

    PubMed  Google Scholar 

  34. Rao AR, Das MG, Das P: Inhibitory action of aminoglutethimide on DMBA-induced mammary carcinogenesis. Oncology 42: 119–121, 1985

    PubMed  Google Scholar 

  35. King RJB, Gordon J, Helfenstein JE: The metabolism of testosterone by tissue from normal and neoplastic rat breast. J Endocrinol 29: 103–110, 1964

    PubMed  Google Scholar 

  36. Bird CE, Morrow L, Fukumoto Y, Marcellus S, Clark AF: Δ5-androstene-diol: kinetics of metabolism and binding to plasma proteins in normal men and women. J Clin Endocrinol Metab 43: 1317–1322, 1976

    PubMed  Google Scholar 

  37. Bird CE, Murphy J, Boroomand K, Finnis W, Dressel D, Clark AF: Dehydroepiandrosterone: kinetics of metabolism in normal men and women. J Clin Endocrinol Metab 47: 818–822, 1978

    PubMed  Google Scholar 

  38. Adams JB, Archibald L, Seymour-Munn K: Dehydroepiandrosterone and androst-5-ene-3β,17β-diol in human mammary cancer cytosolic and nuclear compartments and their relationship to estrogen receptor. Cancer Res 40: 3815–3820, 1980

    PubMed  Google Scholar 

  39. Bonney RC, Scanlon MJ, Reed, MJ, Jones DL, Beranek PA, James VHT: Adrenal androgen concentrations in breast tumours and in normal breast tissue. The relationship to oestradiol metabolism. J Steroid Biochem 20: 501–504, 1984

    PubMed  Google Scholar 

  40. Van Landeghem AAJ, Poortman J, Nabuurs M, Thijssen JHH: Endogenous concentration and subcellular distribution of androgens in normal and malignant human breast tissue. Cancer Res 45: 2907–2912, 1985

    PubMed  Google Scholar 

  41. Adams JB, Wang MSF: Paraendocrine behaviour of human breast carcinoma.In vitro transformation of steroids to physiologically active hormones. J Endocrinol 41: 41–52, 1968

    Google Scholar 

  42. Li K, Foo T, Adams JB: Products of dehydroepiandrosterone metabolism by human mammary tumors and their influence on estradiol receptor binding. Steroids 31: 113–127, 1978

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. MRC Group in Molecular Endocrinology, Laval University Medical Center, G1V 4G2, Quebec, Canada

    Sophie Dauvois & Fernand Labrie

Authors
  1. Sophie Dauvois
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fernand Labrie
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

F.L. is a MRC Career Investigator.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dauvois, S., Labrie, F. Androstenedione and androst-5-ene-3β,17β-diol stimulate DMBA-induced rat mammary tumors — role of aromatase. Breast Cancer Res Tr 13, 61–69 (1989). https://doi.org/10.1007/BF01806551

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01806551

Key words

Search

Navigation